Physician profile
Brandy Rambin
NPI 1235513151
$4,627.01
in general payments reported to CMS, 2019-2025
29 companies · $1,829 in 2025
The $1,829 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.74 · 2022: $532 · 2023: $1,156 · 2024: $1,061 · 2025: $1,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,045.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $925.20 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $773.44 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $515.04 | 2022-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $439.26 | 2022-2025 | Lifevest |
| Pfizer INC. | $371.84 | 2021-2025 | |
| Inari Medical, INC. | $197.56 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $193.00 | 2022-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.47 | 2022-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $101.69 | 2024-2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $84.96 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $82.51 | 2023-2025 | Eliquis, Camzyos |
| Actelion Pharmaceuticals US, INC. | $74.97 | 2022-2025 | Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $70.47 | 2023-2025 | |
| Daiichi Sankyo INC. | $67.82 | 2022-2023 | Injectafer |
| Stryker Corporation | $66.61 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $63.42 | 2021-2022 | |
| Itamar Medical INC | $58.55 | 2022-2023 | Watchpatone |
| Kiniksa Pharmaceuticals, Ltd. | $55.72 | 2022-2023 | Arcalyst |
| Novo Nordisk INC | $52.99 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $45.00 | 2022-2024 | Xarelto |
| Boston Scientific Corporation | $40.64 | 2024-2025 | Bodyguardian |
| Cvrx, INC. | $37.54 | 2024 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $33.43 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $28.92 | 2025 | |
| Innovation Technologies INC | $19.01 | 2024 | Irrisept |
| Phathom Pharmaceuticals, INC. | $16.21 | 2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $16.17 | 2023 | |
| Alnylam Pharmaceuticals INC. | $15.85 | 2025 | Amvuttra |
| Astrazeneca Pharmaceuticals Lp | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Rambin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.